MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Amedisys Company Profile (NASDAQ:AMED)

Consensus Ratings for Amedisys (NASDAQ:AMED) (?)
Ratings Breakdown: 5 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.44)
Consensus Price Target: $51.29 (0.62% upside)

Analysts' Ratings History for Amedisys (NASDAQ:AMED)
Show:
DateFirmActionRatingPrice TargetActions
6/16/2016StephensInitiated CoverageEqual Weight$55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/25/2016Jefferies GroupReiterated RatingBuy$59.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Robert W. BairdReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2016Royal Bank Of CanadaBoost Price TargetSector Perform$41.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Oppenheimer Holdings Inc.Reiterated RatingBuy$56.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/11/2016MizuhoReiterated RatingBuy$49.00 -> $57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/11/2016Raymond James Financial Inc.UpgradeUnderperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2015Piper Jaffray Cos.Reiterated RatingNeutral$42.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/1/2015Wells Fargo & Co.Initiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2015Deutsche Bank AGUpgradeHold -> Buy$28.00 -> $41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2015SunTrust Banks Inc.UpgradeNeutral -> Buy$31.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2014Credit Suisse Group AGReiterated RatingUnderperform$17.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for Amedisys (NASDAQ:AMED)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/27/2016        
5/3/2016Q1$0.33$0.33$337.07 million$348.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2016Q415$0.35$0.40$338.37 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315$0.34$0.34$312.22 million$326.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2015Q215$0.33$0.43$307.11 million$314.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2015Q115$0.20$0.30$300.17 million$301.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2015Q414$0.27$0.27$301.62 million$300.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2014Q314$0.15$0.26$299.26 million$300.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2014Q214$0.04$0.25$298.90 million$305.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014Q114$0.56($0.07)$301.89 million$298.74 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2014Q413($0.01)($0.05)$295.02 million$303.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2013Q313$0.13$0.06$314.30 million$301.64 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2013Q2 2013$0.10$0.06$328.02 million$313.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2013Q1 2013$0.18$0.13$361.41 million$339.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2013Q4 2012$0.22$0.24$373.31 million$632.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2012Q312$0.27$0.33$379.97 million$375.62 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2012$0.24$0.27ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2012$0.22$0.22ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2012$0.29$0.25ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2011$0.50$0.36ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2011$0.69$0.75ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2011$0.66$0.53ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/22/2011$0.91$0.77ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Amedisys (NASDAQ:AMED)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20167$0.32$0.35$0.33
Q2 20165$0.38$0.44$0.42
Q3 20165$0.40$0.46$0.44
Q4 20163$0.49$0.55$0.53
Q1 20172$0.41$0.48$0.45
Q2 20172$0.51$0.56$0.54
Q3 20172$0.56$0.57$0.57
Q4 20172$0.62$0.63$0.63
(Data provided by Zacks Investment Research)
Dividend History for Amedisys (NASDAQ:AMED)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Amedisys (NASDAQ:AMED)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/13/2016Bruce D PerkinsDirectorBuy1,000$50.21$50,210.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/11/2016Scott G GinnInsiderSell6,000$51.62$309,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015North Tide Capital, LlcMajor ShareholderSell277,720$39.79$11,050,478.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2015North Tide Capital, LlcMajor ShareholderSell191,400$39.86$7,629,204.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/26/2015North Tide Capital, LlcMajor ShareholderSell56,400$39.32$2,217,648.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015Donald A WashburnDirectorSell20,000$45.51$910,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2015Jeffrey D JeterInsiderSell11,264$27.02$304,353.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2015Peter RicchiutiDirectorSell2,003$27.25$54,581.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2014Jeffrey D JeterInsiderSell2,500$21.80$54,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2014North Tide Capital, Llcmajor shareholderBuy500,000$13.90$6,950,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014North Tide Capital, Llcmajor shareholderBuy150,000$13.54$2,031,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/21/2013Kkr Asset Management Llcmajor shareholderBuy425,515$14.48$6,161,457.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/15/2013David BuceyGeneral CounselSell8,290$13.95$115,645.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2013Kkr Asset Management Llcmajor shareholderBuy946,500$13.89$13,146,885.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2013Kkr Asset Management LlcMajor ShareholderBuy29,615$15.94$472,063.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/22/2013Kkr Asset Management LlcMajor ShareholderBuy186,013$17.55$3,264,528.15View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/18/2013Kkr Asset Management LlcMajor ShareholderBuy12,652$17.95$227,103.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/3/2013Linda J HallDirectorSell1,721$10.65$18,328.65View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Amedisys (NASDAQ:AMED)
DateHeadline
07/01/16 02:28 PMAmedisys Inc (NASDAQ:AMED) Target Price Is $54 - RealistInvestor.com
07/01/16 10:27 AMBrokers Issue Average Price Target Of 41.75 On Amedisys Inc (NASDAQ:AMED) - Fiscal Standard
07/01/16 10:27 AMNorth Tide Capital LLC Decreased Stake in Amedisys INC (NASDAQ:AMED) by $72.00 Million as Shares Rose - Press Telegraph
06/29/16 02:25 PMAmedisys Inc (NASDAQ:AMED) Accounts Payable Stands AT $33.627 - RealistInvestor.com
06/29/16 10:40 AMWatching Stock Volatility for: Amedisys Inc. (NASDAQ:AMED) - Engelwood Daily
06/28/16 02:40 PMTop Stock Pick for Quarter: Amedisys Inc. (NASDAQ:AMED) - Engelwood Daily
06/28/16 02:40 PMCovering the Bases on Amedisys Inc (NASDAQ:AMED): Where is the Stock Going? - Press Telegraph
06/26/16 07:27 AMStephens & Co. Initiates Coverage on Amedisys Inc to Equal-weight - Trade Calls
06/25/16 08:31 AMAmedisys Inc (NASDAQ:AMED): Growth Forecast - RealistInvestor.com
06/24/16 09:10 AMAmedisys Inc (NASDAQ:AMED) Updated Price Targets - FTSE News
06/24/16 09:10 AMNorth Tide Capital LLC Decreased Stake in Amedisys INC (NASDAQ:AMED) by $72.00 Million as Shares Rose - Engelwood Daily
06/23/16 09:53 PMAir Methods Corp. versus Amedisys Inc. Head to Head Compare - CML News
06/20/16 02:21 PMAmedisys, Inc. – Value Analysis (NASDAQ:AMED) : June 20, 2016 -
06/20/16 08:58 AMAmedisys Inc (NASDAQ:AMED): Can It Move Higher? - Street Report
06/19/16 07:13 AMGreen, Anna Faye
06/19/16 07:13 AMAMEDISYS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
06/17/16 07:07 AMAMEDISYS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
06/17/16 07:00 AMAmedisys Brings In David B. Pearce As New Chief Compliance Officer - [GlobeNewswire] - BATON ROUGE, La., June 17, 2016-- David B. Pearce will join Amedisys, Inc., as Senior Vice President and Chief Compliance Officer, effective July 5.. In his new role, Pearce will apply his expertise to ...
06/15/16 02:31 PMAmedisys Inc (NASDAQ:AMED) Accounts Payable Is $33.627 For The Quarter Ended 2016-03-31 - RealistInvestor.com
06/14/16 07:10 AMAmedisys, Inc. breached its 50 day moving average in a Bearish Manner : AMED-US : June 14, 2016 -
06/11/16 07:55 PMAmedisys Inc (NASDAQ:AMED) Brokerage Rating Update - Investor Newswire
06/10/16 10:53 AMAmedisys Inc (NASDAQ:AMED) Low Price Is Set At $45 - RealistInvestor.com
06/09/16 08:21 PMAmedisys Inc. (NASDAQ:AMED) Fundamental Star Rating Report - CML News
06/07/16 08:03 PMAMEDISYS INC. (NASDAQ:AMED) Financial Condition Compared to S&P 500 - CML News
06/06/16 07:42 PMEarnings Surprise in Focus: Amedisys Inc (NASDAQ:AMED) - Investor Newswire
06/05/16 10:22 AMAfter Last Week What Do Analysts Think Of Amedisys Inc (NASDAQ:AMED) - Share Trading News
06/04/16 10:54 AMCan Amedisys Inc (NASDAQ:AMED) Meet Analysts Expectations? - Stocks Daily
06/03/16 03:22 PMAMEDISYS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/03/16 02:28 PMAmedisys Inc (NASDAQ:AMED) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News
06/03/16 02:28 PMNorth Tide Capital LLC Decreased Stake in Amedisys INC (NASDAQ:AMED) by $72.00 Million as Shares Rose - CCH Daily News
06/02/16 08:26 PMStock Review and Earnings Check on Amedisys Inc (NASDAQ:AMED) - HNN - Stock Review and Earnings Check on Amedisys Inc (NASDAQ:AMED)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Amedisys Inc (NASDAQ:AMED) to ...and more »
06/01/16 03:15 PMAmedisys to Present at the Jefferies 2016 Healthcare Conference - [at noodls] - BATON ROUGE, La., June 01, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), one of America's leading healthcare at home companies, today announced that Paul B. Kusserow, President and Chief Executive ...
05/31/16 08:25 AMShare Rating Focus on Amedisys Inc (NASDAQ:AMED) - HNN - Share Rating Focus on Amedisys Inc (NASDAQ:AMED)HNNPresently, Wall Street analysts have given a consensus stock rating of 1.75 on shares of Amedisys Inc (NASDAQ:AMED). Covering analysts will typically provide Buy, Sell, or Hold recommendations based on extensive research. This consensus number is ...and more »
05/28/16 09:38 AMAmedisys Inc (NASDAQ:AMED) Current Deferred Tax Assets At $55.329 Millions - Investor Newswire - Amedisys Inc (NASDAQ:AMED) Current Deferred Tax Assets At $55.329 MillionsInvestor NewswireFor the year ended 2013-12-31, Amedisys Inc (NASDAQ:AMED) recorded change of 2.103 millions in assets/liabilities. This came at $2.103 millions for the quarter closed 2013-12-31. For year ended 2013-12-31 'days sales' reported in receivables was ...
05/27/16 10:43 AMEarnings Review and Stock Rundown for Amedisys Inc (NASDAQ:AMED) - Wall Street Hints and News - Earnings Review and Stock Rundown for Amedisys Inc (NASDAQ:AMED)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Amedisys Inc (NASDAQ:AMED) to post ...and more »
05/26/16 05:23 AMAmedisys Inc (NASDAQ:AMED) Publicized Q1 Results - Street Report - Amedisys Inc (NASDAQ:AMED) Publicized Q1 ResultsStreet ReportAmedisys Inc (NASDAQ:AMED) stock is currently trading 3.7% below its 52-week-high, 82.1% above its 52-week-low. The 1-year stock price history is in the range of $28.71 – $54.29. Amedisys Inc (AMED) has a price to earnings ratio of 45.26 versus ...North Tide Capital LLC Decreased Stake in Amedisys INC (NASDAQ:AMED) by $72.00 Million as Shares RoseCCH Daily NewsAmedisys Inc (NASDAQ:AMED): Analysts Quick Take on EarningsNews TribuneAmedisys Inc (NASDAQ:AMED) EPS Estimate At $0.47Investor Newswireall 5 news articles »
05/19/16 05:56 PMETF’s with exposure to Amedisys, Inc. : May 19, 2016 -
05/17/16 11:12 AMAmedisys, Inc. :AMED-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/06/16 09:24 AMAmedisys to Present at the Bank of America Merrill Lynch Health Care Conference - [at noodls] - BATON ROUGE, La., May 06, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), one of America's leading healthcare at home companies, today announced that Paul B. Kusserow, President and Chief Executive ...
05/06/16 08:56 AMAmedisys (AMED) Lags Q1 Earnings, Revenues Top the Mark -
05/04/16 06:58 PMEdited Transcript of AMED earnings conference call or presentation 4-May-16 3:00pm GMT -
05/04/16 02:38 PMAMEDISYS INC Files SEC form 10-Q, Quarterly Report -
05/03/16 04:50 PMAmedisys Reports First Quarter Financial Results - [at noodls] - BATON ROUGE, La., May 03, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), a leading home health and hospice company, today reported its financial results for the three-month period ended March 31, ...
05/03/16 06:07 AMQ1 2016 Amedisys Inc Earnings Release - After Market Close -
05/02/16 04:32 PMAMEDISYS INC Files SEC form 8-K, Entry into a Material Definitive Agreement -
04/29/16 10:12 AMLatest Analyst Ratings For Amedisys Inc (NASDAQ:AMED) - Share Trading News - Web Breaking NewsLatest Analyst Ratings For Amedisys Inc (NASDAQ:AMED)Share Trading News01/13/2016 – Amedisys Inc had its “neutral” rating reiterated by analysts at Robert W. Baird. They now have a USD 39 price target on the stock. 01/11/2016 – Amedisys Inc had its “market perform” rating reiterated by analysts at Raymond James. 11/27 ...Amedisys Inc (NASDAQ:AMED) Receives $44.44 Average PT from BrokeragesWeb Breaking NewsAmedisys Inc (NASDAQ:AMED) Wall Street Rating in FocusNews TribuneAmedisys Inc (AMED) Hits a New 52-Week HighFinance Dailyall 4 news articles »
04/29/16 10:12 AMAmedisys Inc (AMED) Hits New 52-week High During April 26 Session - Equities.com - Amedisys Inc (AMED) Hits New 52-week High During April 26 SessionEquities.comAmedisys Inc (AMED) hit a new 52-week high yesterday, reaching a peak of $52.54 after opening at $51.32 and closing at $51.99 for a move of 0.81%. Hitting a new 52-week high is a notable milestone for any company, and it can mean a trading opportunity ...and more »
04/29/16 10:12 AMAmedisys Inc (AMED) Hits New 52-week High During April 27 Session - Equities.com - Amedisys Inc (AMED) Hits New 52-week High During April 27 SessionEquities.comAmedisys Inc (AMED) hit a new 52-week high yesterday, reaching a peak of $53.24 after opening at $52.10 and closing at $53.13 for a move of 2.19%. Hitting a new 52-week high is a notable milestone for any company, and it can mean a trading opportunity ...and more »
04/26/16 03:36 PMAmedisys Announces First Quarter Earnings Release and Conference Call Date - [at noodls] - BATON ROUGE, La., April 26, 2016 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), one of America's leading home health and hospice care companies, announced today that it will report results for the first ...
04/26/16 11:04 AMAmedisys Inc (NASDAQ:AMED) Share Rating Recap - B.O.D.Y Confidential - Amedisys Inc (NASDAQ:AMED) Share Rating RecapB.O.D.Y ConfidentialShares of Amedisys Inc (NASDAQ:AMED) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from financial ...
About Amedisys

Amedisys logoAmedisys, Inc. (Amedisys) is a provider of home health and hospice services. The Company offers home health services to the chronic, co-morbid, aging American population. The Company operates through three segments: home health, hospice and personal care. The Company's home health segment delivers a range of services in the homes of individuals recovering from surgery, have a chronic disability or terminal illness or need assistance with completing important personal tasks. The Company's hospice segment provides palliative care and comfort to terminally ill patients and their families. The Company's personal care segment provides patients with assistance with the essential activities of daily living. The Company owns and operates approximately 330 Medicare-certified home healthcare centers, over 80 Medicare-certified hospice care centers and approximately nine personal-care care centers in over 30 states within the United States, the District of Columbia and Puerto Rico.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Home Health Care
  • Sub-Industry: Health Care Services
  • Exchange: NASDAQ
  • Symbol: AMED
  • CUSIP: 02343610
Key Metrics:
  • Previous Close: $50.97
  • 50 Day Moving Average: $50.83
  • 200 Day Moving Average: $44.40
  • P/E Ratio: 44.13
  • P/E Growth: 1.09
  • Market Cap: $1.70B
  • Current Quarter EPS Consensus Estimate: $1.74 EPS
Additional Links:
Amedisys (NASDAQ:AMED) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha